The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Understanding mechanistic and systemic regulation of protein prenyltransferases. The proposed research will expand our understanding of lipid-conjugating enzymes that are critical for a multitude of normal cellular functions. We seek to reveal the basic workings of cells and help to explain the development and complexity of signalling networks in eukaryotic evolution. The findings will enable us to explore and exploit the catalytic properties of these lipid-related enzymes for applications in bi ....Understanding mechanistic and systemic regulation of protein prenyltransferases. The proposed research will expand our understanding of lipid-conjugating enzymes that are critical for a multitude of normal cellular functions. We seek to reveal the basic workings of cells and help to explain the development and complexity of signalling networks in eukaryotic evolution. The findings will enable us to explore and exploit the catalytic properties of these lipid-related enzymes for applications in biotechnology. The ultimate aim is to create novel technologies for protein production, modification and analysis that will accelerate the pace of discovery in protein research, basic cell and organism biology, diagnostics, biotechnology and drug discovery. Read moreRead less
DNA methylation-based diagnosis of cancer and identification of novel therapeutic targets. In our aging society, cancer represents a severe economic and quality-of-life threat. DNA methylation switches genes off, and recently, it was shown that defects in DNA methylation contribute to human diseases including cancer. This project will identify defects in DNA methylation associated with cancer. Identifying these defects will enable us to design non-invasive, early diagnostic tests for cancer on b ....DNA methylation-based diagnosis of cancer and identification of novel therapeutic targets. In our aging society, cancer represents a severe economic and quality-of-life threat. DNA methylation switches genes off, and recently, it was shown that defects in DNA methylation contribute to human diseases including cancer. This project will identify defects in DNA methylation associated with cancer. Identifying these defects will enable us to design non-invasive, early diagnostic tests for cancer on blood or bodily excretions, and to pursue novel therapeutic approaches for treating cancer. The expected outcomes would generate exports to markets in the USA and Europe and replace imports of drugs and technology to treat cancer.Read moreRead less
Special Research Initiatives - Grant ID: SR0567493
Funder
Australian Research Council
Funding Amount
$99,146.00
Summary
E-Services for Comparative Studies in Molecular Biology. The central challenge of post-genomic biology is to exploit the range of sequence and microarray data to yield greater understanding of biological processes. Large comparative studies are hamstrung by the inaccessibility of specialist comparative tools and the problem of managing large-scale disparate data. This project will provide portal and web services facilities to remove these obstacles, relying on robust and scalable business techno ....E-Services for Comparative Studies in Molecular Biology. The central challenge of post-genomic biology is to exploit the range of sequence and microarray data to yield greater understanding of biological processes. Large comparative studies are hamstrung by the inaccessibility of specialist comparative tools and the problem of managing large-scale disparate data. This project will provide portal and web services facilities to remove these obstacles, relying on robust and scalable business technologies to be made freely available. Our work will be driven by specific applications in bacterial genomics and cancer research, and will support research into prostate cancer and the pathogens Chlamydia and Bacillus anthracis.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0668526
Funder
Australian Research Council
Funding Amount
$542,000.00
Summary
Biomolecular discovery and analysis facility. This facility will provide Australian researchers with unrivalled access to advanced cell visualisation and analysis tools, which until very recently were only available to the pharmaceutical industry and large US and European institutions. The facility will allow new approaches to identifying novel natural products and understanding cell signalling pathways. Knowledge of these pathways and the identification of molecules that can affect them are key ....Biomolecular discovery and analysis facility. This facility will provide Australian researchers with unrivalled access to advanced cell visualisation and analysis tools, which until very recently were only available to the pharmaceutical industry and large US and European institutions. The facility will allow new approaches to identifying novel natural products and understanding cell signalling pathways. Knowledge of these pathways and the identification of molecules that can affect them are keys to understanding normal cellular physiology and identifying drug-like molecules able to inhibit malfunctioning pathways found in different disease such as cancer. The facility will accellerate drug discovery and basic research in cell biology and underpin National Research Priorities.Read moreRead less
Characterisation and improvement of radiation beams used for radiotherapy of small lesions. This project aims to characterise the radiation dose from a medical linear accelerator after the beam has been shaped by a mini-multileaf collimator. The characterisation will be achieved through a combination of computer simulations and experimental investigation of the beam using the technique of three-dimensional gel dosimetry. When the dosage characteristics are known, techniques will be developed to ....Characterisation and improvement of radiation beams used for radiotherapy of small lesions. This project aims to characterise the radiation dose from a medical linear accelerator after the beam has been shaped by a mini-multileaf collimator. The characterisation will be achieved through a combination of computer simulations and experimental investigation of the beam using the technique of three-dimensional gel dosimetry. When the dosage characteristics are known, techniques will be developed to improve radiotherapy treatments in patients with small lesions with sizes of up to a few centimetres. This will lead to an improved outcome for some cancer patients.Read moreRead less
The development of a rapid diagnostic test for heparanase activity. Heparanase is an enzyme that has been implicated in a number of disease states such as cancer, arthritis, multiple sclerosis and other inflammatory diseases. Characterisation of this enzyme has been slow, due in part to the lack of a reliable direct activity assay. Using a multi-disciplinary approach, this project seeks to establish a rapid assay that will provide easy determination of heparanase activity. Furthermore, this a ....The development of a rapid diagnostic test for heparanase activity. Heparanase is an enzyme that has been implicated in a number of disease states such as cancer, arthritis, multiple sclerosis and other inflammatory diseases. Characterisation of this enzyme has been slow, due in part to the lack of a reliable direct activity assay. Using a multi-disciplinary approach, this project seeks to establish a rapid assay that will provide easy determination of heparanase activity. Furthermore, this assay could provide a useful diagnostic tool in a clinical environment that would allow for the rapid assessment of these diseases, their progression and indeed response to therapy.Read moreRead less
The role of human single-stranded binding protein (hSSB1) in DNA damage repair and tumorogenesis. Cancer is a leading cause of disease related death world wide, accounting for over 13% of all deaths in 2007. Approximately 38,000 people died in Australia from cancer in 2005. Cancer results from a single cell losing a vital part of its genetic information, this results in the cell losing its normal programming and initiates a process of rapid growth and multiplication. This research project aims t ....The role of human single-stranded binding protein (hSSB1) in DNA damage repair and tumorogenesis. Cancer is a leading cause of disease related death world wide, accounting for over 13% of all deaths in 2007. Approximately 38,000 people died in Australia from cancer in 2005. Cancer results from a single cell losing a vital part of its genetic information, this results in the cell losing its normal programming and initiates a process of rapid growth and multiplication. This research project aims to look at the mechanisms that exist to prevent this initial loss of genetic material within an individual cell. It further aims to translate theses discoveries into the clinic, providing new tools for diagnosis and prognosis of specific cancers and to establish links with major pharmaceutical companies to develop novel anticancer therapies.Read moreRead less
Bayesian statistical models for understanding outcomes and improving decision-making for women screened for breast cancer. This project has two key benefits: (i) the development of frontier statistical methods for spatio-temporal analysis and data synthesis, which are imperative in a wide range of disciplines; and (ii) the application of these methods for improved understanding of breast cancer outcomes for women screened in Queensland. The project results will lead to direct health and financi ....Bayesian statistical models for understanding outcomes and improving decision-making for women screened for breast cancer. This project has two key benefits: (i) the development of frontier statistical methods for spatio-temporal analysis and data synthesis, which are imperative in a wide range of disciplines; and (ii) the application of these methods for improved understanding of breast cancer outcomes for women screened in Queensland. The project results will lead to direct health and financial benefits through targeted policies for increasing screening uptake and reducing cancer morbidity and mortality and therefore health spending in this area. Importantly, the project represents an excellent training opportunity to develop a PhD candidate into an experienced interdisciplinary researcher.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0346702
Funder
Australian Research Council
Funding Amount
$193,000.00
Summary
High Performance Liquid Chromatography - Inductively Coupled Plasma - Mass Spectrometry (HPLC-ICPMS). HPLC-ICP-MS is the most reliable cutting edge technology for speciation of metals and metalloids in biological and environmental matrices, and is essential for toxicological studies, which is a major aim behind NRCET's establishment. It will provide a very powerful utility to fill a badly needed knowledge gap for our research and serve the needs of both postgraduate students and postdoctoral fel ....High Performance Liquid Chromatography - Inductively Coupled Plasma - Mass Spectrometry (HPLC-ICPMS). HPLC-ICP-MS is the most reliable cutting edge technology for speciation of metals and metalloids in biological and environmental matrices, and is essential for toxicological studies, which is a major aim behind NRCET's establishment. It will provide a very powerful utility to fill a badly needed knowledge gap for our research and serve the needs of both postgraduate students and postdoctoral fellows. This technology will provide new opportunities in research. It will strengthen our linkages within Faculty of Heath Sciences and with our research partners in CQU, QUT and Griffith and enforce our strong national and international reputation.Read moreRead less
Redox-Tuneable Sensitisers for Photodynamic Therapy of Malignant and Non-Malignant Proliferative Diseases. Cancer is currently Australia's leading cause of death with 85 231 new cases reported during 2000, costing the health system >$2 billion annually. Photodynamic Therapy is a promising anti-cancer therapy which combines the action of a photosensitising drug and light to destroy tumours. This project will lead to the development of new photosensitisers which will enable the specific targeting ....Redox-Tuneable Sensitisers for Photodynamic Therapy of Malignant and Non-Malignant Proliferative Diseases. Cancer is currently Australia's leading cause of death with 85 231 new cases reported during 2000, costing the health system >$2 billion annually. Photodynamic Therapy is a promising anti-cancer therapy which combines the action of a photosensitising drug and light to destroy tumours. This project will lead to the development of new photosensitisers which will enable the specific targeting of tumours while protecting healthy tissue from damage. Post-treatment skin photosensitivity will be minimised by antioxidant features integrated into the photosensitisers. The development of improved photosensitisers during this project will ultimately lead to improved treatment and new alternatives for Australian cancer sufferers.Read moreRead less